Cardiologists' experiences and perceptions of patient involvement and communication related to shared decision-making

Eleni Siouta1, Ulla Hellström Muhli2, Bjöörn Fossum3

  • 1Karolinska Institutet.

Insights

Cardiologists

Area of Science:

  • Cardiology
  • Medical Communication
  • Patient Engagement

Background:

  • Patient involvement in treatment decisions is crucial for atrial fibrillation (AF) care.
  • Supportive communication from cardiologists enhances patient engagement in AF treatment.
  • Understanding cardiologists' perspectives on patient involvement is essential for improving care.

Purpose of the Study:

  • To explore cardiologists' descriptions of patient involvement in AF treatment decisions.
  • To examine cardiologists' perceptions of communication strategies for shared decision-making in AF care.
  • To understand cardiologists' views on current efforts to involve patients in AF treatment decisions.

Main Methods:

  • Qualitative content analysis of interviews with ten cardiologists.
  • Interviews conducted across four Swedish hospitals.
  • Exploration of cardiologists' experiences and viewpoints on patient involvement.

Main Results:

  • Cardiologists frame patient involvement through ideology, experience, and responsibility.
  • Communication and supportive interactions are key elements in fostering patient involvement.
  • Perceptions of patient involvement vary based on these three framing factors.

Conclusions:

  • Actively encouraging patient involvement and considering their feelings enhances engagement in AF treatment decisions.
  • Improving physician-patient communication is vital for meeting legislative goals for patient involvement.
  • Optimizing conditions for patient involvement in decision-making can improve treatment compliance.
Abstract

Related Concept Videos

Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...